299 related articles for article (PubMed ID: 29203371)
1. High glucose up-regulates Semaphorin 3A expression via the mTOR signaling pathway in keratinocytes: A potential mechanism and therapeutic target for diabetic small fiber neuropathy.
Wu LY; Li M; Qu ML; Li X; Pi LH; Chen Z; Zhou SL; Yi XQ; Shi XJ; Wu J; Wang S
Mol Cell Endocrinol; 2018 Sep; 472():107-116. PubMed ID: 29203371
[TBL] [Abstract][Full Text] [Related]
2. Expression of macrophage migration inhibitory factor in footpad skin lesions with diabetic neuropathy.
Noh SU; Lee WY; Kim WS; Lee YT; Yoon KJ
Mol Pain; 2018; 14():1744806918775482. PubMed ID: 29690804
[TBL] [Abstract][Full Text] [Related]
3. Increased Epidermal Nerve Growth Factor without Small-Fiber Neuropathy in Dermatomyositis.
Wong LS; Lee CH; Yen YT
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012289
[TBL] [Abstract][Full Text] [Related]
4. Lycium barbarum polysaccharide protects diabetic peripheral neuropathy by enhancing autophagy via mTOR/p70S6K inhibition in Streptozotocin-induced diabetic rats.
Liu SY; Chen L; Li XC; Hu QK; He LJ
J Chem Neuroanat; 2018 Apr; 89():37-42. PubMed ID: 29294366
[TBL] [Abstract][Full Text] [Related]
5. Activation of mTOR signaling mediates the increased expression of AChE in high glucose condition: in vitro and in vivo evidences.
Liu YW; Zhang L; Li Y; Cheng YQ; Zhu X; Zhang F; Yin XX
Mol Neurobiol; 2016 Sep; 53(7):4972-80. PubMed ID: 26374551
[TBL] [Abstract][Full Text] [Related]
6. mTORC1 is a critical mediator of oncogenic Semaphorin3A signaling.
Yamada D; Kawahara K; Maeda T
Biochem Biophys Res Commun; 2016 Aug; 476(4):475-480. PubMed ID: 27246732
[TBL] [Abstract][Full Text] [Related]
7. Diabetes Perturbs Bone Microarchitecture and Bone Strength through Regulation of Sema3A/IGF-1/β-Catenin in Rats.
Ma R; Wang L; Zhao B; Liu C; Liu H; Zhu R; Chen B; Li L; Zhao D; Mo F; Li Y; Niu J; Jiang G; Fu M; Bromme D; Gao S; Zhang D
Cell Physiol Biochem; 2017; 41(1):55-66. PubMed ID: 28135705
[TBL] [Abstract][Full Text] [Related]
8. Calcium-Inducible MAPK/AP-1 Signaling Drives Semaphorin 3A Expression in Normal Human Epidermal Keratinocytes.
Kamata Y; Tominaga M; Umehara Y; Honda K; Kamo A; Moniaga CS; Komiya E; Toyama S; Suga Y; Ogawa H; Takamori K
J Invest Dermatol; 2020 Jul; 140(7):1346-1354.e5. PubMed ID: 31945349
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin blocks the IL-13-induced deficiency of Epidermal Barrier Related Proteins via upregulation of miR-143 in HaCaT Keratinocytes.
Jia QN; Zeng YP
Int J Med Sci; 2020; 17(14):2087-2094. PubMed ID: 32922169
[TBL] [Abstract][Full Text] [Related]
10. Sema 3A as a biomarker of the activated mTOR pathway during hexavalent chromium-induced acute kidney injury.
Song MF; Yang Y; Yi ZW; Zhang ZQ; Shen XD; Hu GH; Zhu YF
Toxicol Lett; 2018 Dec; 299():226-235. PubMed ID: 30236763
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Assessment of Small Fiber Neuropathy: Evidence of a Non-Length-Dependent Distal Axonopathy.
Khoshnoodi MA; Truelove S; Burakgazi A; Hoke A; Mammen AL; Polydefkis M
JAMA Neurol; 2016 Jun; 73(6):684-90. PubMed ID: 27065313
[TBL] [Abstract][Full Text] [Related]
12. NRP-1 Receptor Expression Mismatch in Skin of Subjects with Experimental and Diabetic Small Fiber Neuropathy.
Van Acker N; Ragé M; Vermeirsch H; Schrijvers D; Nuydens R; Byttebier G; Timmers M; De Schepper S; Streffer J; Andries L; Plaghki L; Cras P; Meert T
PLoS One; 2016; 11(9):e0161441. PubMed ID: 27598321
[TBL] [Abstract][Full Text] [Related]
13. Impact on Autophagy and Ultraviolet B Induced Responses of Treatment with the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and pp242 in Human Keratinocytes.
Xu S; Li L; Li M; Zhang M; Ju M; Chen X; Gu H
Oxid Med Cell Longev; 2017; 2017():5930639. PubMed ID: 28400912
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal administration of rapamycin inhibits the phosphorylation of DRG Nav1.8 and attenuates STZ-induced painful diabetic neuropathy in rats.
He WY; Zhang B; Xiong QM; Yang CX; Zhao WC; He J; Zhou J; Wang HB
Neurosci Lett; 2016 Apr; 619():21-8. PubMed ID: 26946108
[TBL] [Abstract][Full Text] [Related]
15. The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy.
Lu Q; Zhou Y; Hao M; Li C; Wang J; Shu F; Du L; Zhu X; Zhang Q; Yin X
Mol Cell Endocrinol; 2018 Sep; 473():31-43. PubMed ID: 29277549
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-derived secretory factor downregulates Semaphorin-3a in osteoblasts by activating mammalian target of rapamycin pathway.
Yamada D; Kawahara K; Ozaki M; Maeda T
Biosci Biotechnol Biochem; 2016 May; 80(5):942-4. PubMed ID: 26865270
[TBL] [Abstract][Full Text] [Related]
17. Phospho-mTOR: a novel target in regulation of renal lipid metabolism abnormality of diabetes.
Hao J; Zhu L; Li F; Liu Q; Zhao X; Liu S; Xing L; Feng X; Duan H
Exp Cell Res; 2013 Aug; 319(14):2296-306. PubMed ID: 23827786
[TBL] [Abstract][Full Text] [Related]
18. DJ-1 overexpression restores ischaemic post-conditioning-mediated cardioprotection in diabetic rats: role of autophagy.
Zhou B; Lei S; Xue R; Leng Y; Xia Z; Xia ZY
Clin Sci (Lond); 2017 Jun; 131(11):1161-1178. PubMed ID: 28404768
[TBL] [Abstract][Full Text] [Related]
19. Function of Adenosine 2A Receptor in High-Fat Diet-Induced Peripheral Neuropathy.
Li J; Liu HQ; Li XB; Yu WJ; Wang T
J Diabetes Res; 2020; 2020():7856503. PubMed ID: 32566683
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
